Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,277 | -13,965 | -9,567 | -5,542 | -15,132 |
| Depreciation Amortization | 958 | 830 | 737 | 621 | 2,091 |
| Accounts payable and accrued liabilities | 4,645 | 947 | 853 | 560 | 88 |
| Other Working Capital | 4,361 | 314 | 136 | 476 | 1,009 |
| Other Operating Activity | 5,982 | 4,948 | 4,208 | 2,626 | 8,471 |
| Operating Cash Flow | $-11,331 | $-6,926 | $-3,633 | $-1,259 | $-3,473 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -50 | -25 | N/A | N/A | N/A |
| PPE Investments | -181 | -144 | -56 | -9 | N/A |
| Other Investing Activity | -1,304 | -600 | -600 | -500 | -70 |
| Investing Cash Flow | $-1,535 | $-769 | $-656 | $-509 | $-70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 500 | N/A | N/A |
| Debt Issued | 500 | N/A | N/A | 500 | 5,048 |
| Debt Repayment | -9 | N/A | N/A | N/A | -304 |
| Common Stock Issued | 8,049 | 6,851 | 4,167 | 4,000 | N/A |
| Other Financing Activity | 3,507 | 491 | -9 | 0 | -325 |
| Financing Cash Flow | $12,047 | $7,342 | $4,658 | $4,500 | $4,419 |
| Beginning Cash Position | 1,033 | 1,033 | 1,033 | 1,033 | 157 |
| End Cash Position | 214 | 680 | 1,402 | 3,765 | 1,033 |
| Net Cash Flow | $-819 | $-353 | $369 | $2,732 | $876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,331 | -6,926 | -3,633 | -1,259 | -3,473 |
| Capital Expenditure | -181 | -144 | -56 | -9 | N/A |
| Free Cash Flow | -11,512 | -7,070 | -3,689 | -1,268 | -3,473 |